8U8X
crystal structure of the receptor tyrosine kinase Human HER2 (ERBB2) YVMA mutant kinase domain in complex with inhibitor compound 27
Summary for 8U8X
Entry DOI | 10.2210/pdb8u8x/pdb |
Descriptor | Receptor tyrosine-protein kinase erbB-2, 1-{(1R,3r,5S)-3-[(3M)-4-methyl-3-{3-methyl-4-[(1-methyl-1H-benzimidazol-5-yl)oxy]phenyl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-8-azabicyclo[3.2.1]octan-8-yl}propan-1-one, DI(HYDROXYETHYL)ETHER, ... (5 entities in total) |
Functional Keywords | proto-oncogene c-erbb-2, tyrosine kinase-type cell surface, signaling protein, transferase-inhibitor complex, transferase/inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 40200.76 |
Authors | |
Primary citation | Hicken, E.J.,Brown, K.,Dwulet, N.C.,Gaudino, J.J.,Hansen, E.P.,Hartley, D.P.,Kowalski, J.P.,Laird, E.R.,Lazzara, N.C.,Li, B.,Mou, T.C.,Mutryn, M.F.,Oko, L.,Pajk, S.,Pipal, R.W.,Rosen, R.Z.,Shelp, R.,Singh, A.,Wang, J.,Wise, C.E.,Wong, C.,Wong, J.Y. Discovery of Potent and Selective Covalent Inhibitors of HER2 WT and HER2 YVMA . J.Med.Chem., 67:9759-9771, 2024 Cited by PubMed: 38820338DOI: 10.1021/acs.jmedchem.4c00978 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.69 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)